Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 116

Results For "LA"

8534 News Found

AstraZeneca Pharma India to launch Enhertu in January 2024
News | December 20, 2023

AstraZeneca Pharma India to launch Enhertu in January 2024

Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer


Zydus receives final approval from the USFDA for Lacosamide Tablets
Drug Approval | December 18, 2023

Zydus receives final approval from the USFDA for Lacosamide Tablets

Lacosamide is indicated to treat partial-onset seizures


Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
News | December 18, 2023

Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries

10+ emerging markets, Japan & ANZ transition in final phase


Briefs: Torrent Pharmaceuticals and Laurus Synthesis
News | December 17, 2023

Briefs: Torrent Pharmaceuticals and Laurus Synthesis

Laurus Synthesis receives Form 483 with 5 observations from USFDA


Lupin Diagnostics opens new laboratory in Chennai
News | December 17, 2023

Lupin Diagnostics opens new laboratory in Chennai

The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies


Panacea Biotec launches EasyFourPol in India
News | December 17, 2023

Panacea Biotec launches EasyFourPol in India

Receives registration of Valganciclovir powder for oral solution in Germany


Cipla to further invest Rs. 42 crore in GoApptiv
Digitisation | December 17, 2023

Cipla to further invest Rs. 42 crore in GoApptiv

Expands patient reach to remotest towns by furthering investment in GoApptiv


TÜV SÜD inaugurates € 15 million Laboratory & Training Centre Bengaluru Campus
News | December 17, 2023

TÜV SÜD inaugurates € 15 million Laboratory & Training Centre Bengaluru Campus

Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services


Granules India received ANDA approval for Pantoprazole Sodium Delayed-Release Tablets
Drug Approval | December 14, 2023

Granules India received ANDA approval for Pantoprazole Sodium Delayed-Release Tablets

Pantoprazole Sodium Delayed-Release Tablets are indicated for short-term treatment of Erosive Esophagitis associated with GERD